Covid: What led to DCGI nod of Covishield & Covaxin in India? IMCR DG explains
Published on Jan 05, 2021 07:35 pm IST
ICMR DG Dr. Balram Bhargava explained the DCGI nod to two Covid-19 vaccines in India. Dr. Bhargava spoke on the various studies done over Covishield and Covaxin. Covishield Oxford-AstraZeneca vaccine which is manufactured at Pune's Serum Institute of India (SII). Covishield was the first vaccine in India to get the DCGI nod. Soon after, DCGI approved Covaxin. Watch the full video for more details.
RELATED VIDEOS
India Silently Rushes Warships Near Houthi Territory After U.S. Forms Red Sea Force | Watch
Published on Dec 19, 2023 08:38 pm IST
India calls-out W.H.O Covid death data at Geneva; conveys ‘disappointment’
Published on May 24, 2022 07:41 am IST
Paid Covid booster doses for Indian adults: Prices, Availability | Key details
Published on Jul 25, 2023 03:21 pm IST
How Shanghai is grappling with biggest-ever Covid outbreak
Published on Apr 06, 2022 11:08 pm IST
XE a ‘recombinant’: What we know of the new Covid variant reported from Mumbai
Published on Apr 06, 2022 09:56 pm IST
PM Modi clarifies on migrant crisis; says, ‘States imposed lockdown first’
Published on Feb 10, 2022 09:08 am IST
Hi, {{name}}
Sign out
{{planName}}
{{^userSubscribed}}
{{/userSubscribed}}